Author:
Daniels Brodie,Kuhn Louise,Spooner Elizabeth,Mulol Helen,Goga Ameena,Feucht Ute,Essack Sabiha Y,Coutsoudis Anna
Reference30 articles.
1. Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, Côte d'Ivoire: a randomised trial;Anglaret;Lancet,1999
2. Provisional WHO/UNAIDS Secretariat recommendations on the use of cotrimoxazole prophylaxis in adults and children living with HIV/AIDS in Africa;Afr Health Sci,2000
3. Effect of co-trimoxazole on mortality in HIV-exposed but uninfected children in Botswana (the Mpepu Study): a double-blind, randomised, placebo-controlled trial;Lockman;Lancet Glob Health,2017
4. Effect of co-trimoxazole prophylaxis on morbidity and mortality of HIV-exposed, HIV-uninfected infants in South Africa: a randomised controlled, non-inferiority trial;Daniels;Lancet Glob Health,2019
5. Cotrimoxazole prophylaxis increases resistance gene prevalence and α-diversity but decreases β-diversity in the gut microbiome of human immunodeficiency virus-exposed, uninfected infants;D'Souza;Clin Infect Dis,2020